NewGenIvf Group Limited (NIVFW) Comparison with companies in other sectors?

NewGenIvf Group Limited has a share price of 191.91M. You can analyze NewGenIvf Group Limited (NIVFW) competitors across different market sectors through stock heatmaps.

What are NIVFW's NET and operating margins?

NewGenIvf Group Limited (NIVFW) operating margin is around -0.21, and net profit margin is approximately -0.10 as of the latest reports.

In what way does NIVFW's earnings per share (EPS) trend reflect its financial momentum?

NewGenIvf Group Limited (NIVFW) EPS is N/A (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for NewGenIvf Group Limited is N/A, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for NewGenIvf Group Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for NewGenIvf Group Limited like P/E which is 0.00, P/B which is 0.00, and PEG which is 0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

NewGenIvf Group Limited

NIVFW•NASDAQ

Healthcare

Medical - Care Facilities

$0.03

$0.006(26.61%)

Fundamental Analysis of NewGenIvf Group Limited (NIVFW)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

P/E Ratio

ROE

-0.39%

Net Margin

-0.10%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$5.66M

Shares OutstandingTotal number of shares issued

$191.91M

Book Value/ShareNet worth per share

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

Net MarginNet income as percentage of revenue

-9.66%

Operating MarginOperating income as percentage of revenue

-21.36%

ROEReturn on shareholders' equity

-39.05%

ROAReturn on total assets

-14.66%

ROCEReturn on capital employed

-135.35%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

FCF YieldFree cash flow as percentage of market cap

-146.91%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for NIVFWFinancial Ratios Analysis details for NIVFW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for NIVFWSector Benchmarking details for NIVFW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for NewGenIvf Group Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of NewGenIvf Group Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account NewGenIvf Group Limited's unique business strengths and challenges.

Key Financial Metrics for NewGenIvf Group Limited

For NewGenIvf Group Limited, essential financial indicators include EPS -, PE -, and ROE -0.39. These key ratios reveal insights into NewGenIvf Group Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare NewGenIvf Group Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of NewGenIvf Group Limited

Metrics like Net Margin -9.66% and ROA -14.66% shed light on how well NewGenIvf Group Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether NewGenIvf Group Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of NewGenIvf Group Limited

Using ratios such as P/B Ratio - and PEG Ratio -, investors can assess whether NewGenIvf Group Limited is appropriately valued based on its financials and growth potential. These figures, combined with NewGenIvf Group Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for NewGenIvf Group Limited

Financial health indicators, such as Debt/Equity Ratio -2.89 and Cash Flow -, provide a snapshot of NewGenIvf Group Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like NewGenIvf Group Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for NewGenIvf Group Limited

Investing in NewGenIvf Group Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at NewGenIvf Group Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;